Q1 2021 Holdings
Filed 2021-05-17 | 126 holdings | $7.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $4.1B | 11,668,897 | 56.2% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.1B | 41,910,704 | 15.0% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $573.1M | 7,589,294 | 7.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $456.3M | 3,540,270 | 6.3% |
| AbCellera Biologics Inc.(ABCL) | COM | 00288U106 | $354.9M | 10,450,180 | 4.9% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $308.3M | 1,119,557 | 4.3% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $129.3M | 12,710,818 | 1.8% |
| Cerus Corporation(CERS) | COM | 157085101 | $82.4M | 13,713,195 | 1.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $52.2M | 9,830,877 | 0.7% |
| Altimmune, Inc.(ALT) | COM | 02155H200 | $39.0M | 2,758,518 | 0.5% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $35.6M | 628,414 | 0.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $18.3M | 1,410,064 | 0.3% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $9.4M | 616,520 | 0.1% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $7.1M | 636,363 | 0.1% |
| Seagen Inc.(SGENUSD) | COM | 81181C104 | $6.6M | 47,270,759 | 0.1% |
| Alector, Inc.(ALEC) | COM | 014442107 | $4.8M | 239,228 | 0.1% |
| Autolus Therapeutics plc(AUTL) | SPONSORED ADS | 05280R100 | $2.6M | 461,726 | 0.0% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.6M | 32,001,387 | 0.0% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $1.6M | 13,879,952 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $610.6K | 3,993,312 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $601.8K | 15,749,182 | 0.0% |
| Prelude Therapeutics Incorporated(PRLD) | COM | 74065P101 | $438.7K | 10,123,824 | 0.0% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $242.0K | 3,156,102 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $241.5K | 1,409,784 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $175.4K | 1,499,213 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR | 023111206 | $164.3K | 26,453,422 | 0.0% |
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $131.1K | 3,217,441 | 0.0% |
| Immunocore Holdings plc(IMCR) | ADS | 45258D105 | $107.3K | 2,520,730 | 0.0% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $106.7K | 3,201,972 | 0.0% |
| Instil Bio, Inc. | COM | 45783C101 | $97.7K | 3,893,700 | 0.0% |
| Talis Biomedical Corporation | COM | 87424L108 | $97.3K | 7,574,835 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $97.2K | 5,994,704 | 0.0% |
| Allakos Inc.(ALLKGUSD) | COM | 01671P100 | $80.7K | 703,050 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $77.9K | 14,614,264 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $76.3K | 2,454,082 | 0.0% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $76.1K | 1,959,211 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $74.0K | 3,479,873 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $73.4K | 2,156,001 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | COM | 03753U106 | $71.8K | 1,674,004 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $65.8K | 676,975 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $58.6K | 760,412 | 0.0% |
| Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | $56.7K | 2,024,876 | 0.0% |
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $55.1K | 599,110 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A COM | 04965G109 | $54.2K | 3,532,760 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $54.0K | 1,708,472 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $51.8K | 2,799,577 | 0.0% |
| Ultragenyx Pharmaceutical Inc.(RARE) | COM | 90400D108 | $50.6K | 444,444 | 0.0% |
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $47.0K | 3,821,740 | 0.0% |
| Immatics N.V.(IMTX) | SHS | N44445109 | $44.8K | 3,992,756 | 0.0% |
| Design Therapeutics, Inc.(DSGN) | COM | 25056L103 | $43.0K | 1,436,636 | 0.0% |